[Form 4] LiveRamp Holdings, Inc. Insider Trading Activity
Rhea-AI Filing Summary
LiveRamp Holdings, Inc. (RAMP) director Timothy R. Cadogan was issued 1,529 shares of common stock on 08/13/2025 as part of his director compensation. Following the grant, Cadogan beneficially owns 56,999 shares. The shares were issued at no cash price noted on the form and recorded on a Form 4 filed 08/14/2025 by an attorney-in-fact. The filing identifies Cadogan as a director and shows this transaction was an acquisition for compensation purposes. No derivative transactions, dispositions, or additional financial terms appear in the submitted Form 4.
Positive
- Equity alignment: Director received 1,529 shares as compensation, increasing personal stake to 56,999 shares.
- Clear compliance: Transaction reported on Form 4 with required details and signature, meeting Section 16 disclosure requirements.
Negative
- Limited materiality: The grant size is modest and unlikely to be material to company valuation.
- No pricing detail: The form lists the shares as issued for compensation with $0 price shown, providing no cash-value context in this filing.
Insights
TL;DR: Director received a routine equity grant of 1,529 shares as compensation, modest in size relative to typical executive holdings.
This Form 4 reports a standard director equity award rather than a market purchase or sale. The grant increases the director's alignment with shareholders by adding stock-based compensation, and the filing discloses post-transaction beneficial ownership of 56,999 shares. The disclosure is consistent with Section 16 reporting requirements and contains no unusual terms, derivatives, or immediate dispositions.
TL;DR: Filing is procedural and compliant: an award recorded and reported by Form 4 with signature by attorney-in-fact.
The Form 4 shows an acquisition coded as compensation and includes the required reporting fields: issuer, reporting person, transaction date, amount acquired, and resulting beneficial ownership. There are no exercise prices, expiration dates, or derivative instruments disclosed. The signature block indicates filing by attorney-in-fact, which is an acceptable execution method under reporting rules.